Both heterozygous and homozygous α+ thalassemias protect against severe and fatal Plasmodium falciparum malaria on the coast of Kenya

Blood

Volumn 106, Issue 1, 2005, Pages 368-371

  Williams, Thomas N ^a   Wambua, Sammy ^b   Uyoga, Sophie ^b   Macharia, Alex ^b   Mwacharo, Jedidah K ^b   Newton, Charles R J C ^b   Maitland, Kathryn ^b  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA THALASSEMIA; ANEMIA; ARTICLE; CHILD; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; ETHNOLOGY; FATALITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HOSPITAL ADMISSION; HUMAN; INFECTION PREVENTION; KENYA; MAJOR CLINICAL STUDY; MALARIA; PLASMODIUM FALCIPARUM; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

EID: 22044457291     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2005-01-0313     Document Type: Article

References (25)

1. Weatherall DJ, Clegg JB. The thalassaemia syndromes. 3rd ed. Oxford, United Kingdom: Blackwell Scientific Publications; 2002.
2. Allen SJ, O'Donnell A, Alexander ND, et al. Alpha(+)thalassemia protects children against disease caused by other infections as well as malaria. Proc Natl Acad Sci U S A. 1997;94:14736-14741.
3. Mockenhaupt FP, Ehrhardt S, Gellert S, et al. α(+)Thalassaemia protects from severe malaria in African children. Blood. 2004;104:2003-2006.
4. Snow RW, Omumbo JA, Lowe B, et al. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet. 1997;349:1650-1654,
5. Mbogo CN, Snow RW, Kabiru EW, et al. Low-level Plasmodium falciparum transmission and the incidence of severe malaria infections on the Kenyan coast. Am J Trop Med Hyg. 1993;49:245-253.
6. Marsh K, Forster D, Waruiru C, et al. Indicators of life-threatening malaria in African children. N Engl J Med. 1995;332:1399-1404.
7. Berkley JA, Lowe BS, Mwangi I, et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med. 2005;352:39-47.
8. Maitland K, Pamba A, Newton CR, Levin M. Response to volume resuscitation in children with severe malaria. Pediatr Crit Care Med. 2003;4: 426-431.
9. Chong SS, Boehm CD, Higgs DR, Cutting GR. Single-tube multiplex-PCR screen for common deletional determinants of alpha-thalassemia. Blood. 2000;95:360-362.
10. English M, Waruiru C, Amukoye E, et al. Deep breathing in children with severe malaria: Indicator of metabolic acldosis and poor outcome. Am J TropMed Hyg. 1996;55:521-524.
11. Williams TN, Maitland K, Ganczakowski M, et al. Red blood cell phenotypes in the alpha + thalassaemias from early childhood to maturity. Br J Haematol. 1996;95:266-272.
12. Yuthavong Y, Butthep P, Bunyaratvej A, Fucharoen S, Khurmith S. Impaired parasite growth and increased susceptibility to phagocytosis of Plasmodium falciparum infected alpha-thalassemia and hemoglobin Constant Spring red blood cells. Am J Clin Pathol. 1988;89:521-525.
13. Luzzi GA, Merry AH, Newbold CI, Marsh K, Pasvol G, Weatherall DJ. Surface antigen expression on Plasmodium falciparum-infected erythrocytes is modified in alpha- and beta-thalassemia. J Exp Med. 1991;173:785-791.
14. Williams TN, Weatherall DJ, Newbold CI. The membrane characteristics of Plasmodium falciparum-infected and -uninfected heterozygous alpha(0)thalassaemic erythrocytes. Br J Haematol. 2002;118:663-670.
15. Carlson J, Nash GB, Gabutti V, al-Yaman F, Wahlgren M. Natural protection against severe Plasmodium falciparum malaria due to impaired rosette formation. Blood. 1994;84:3909-3914.
16. Mockenhaupt FP, Bienzle U, May J, et al. Plasmodium falciparum infection: influence on hemoglobin levels in alpha-thalassemia and microcytosis. J Infect Dis. 1999;180:925-928.
17. Mockenhaupt FP, Falusi AG, May J, et al. The contribution of alpha+-thalassaemia to anaemia in a Nigerian population exposed to intense malaria transmission. Trop Med Int Health. 1999;4: 302-307.
18. Mockenhaupt FP, May J, Bergqvist Y, Meyer CG, Falusi AG, Bienzle U. Evidence for a reduced effect of chloroquine against Plasmodium falciparum in alpha-thalassaemic children. Trop Med Int Health. 2001;6:102-107.
19. Williams TN. Mechanisms of malaria protection in the thalassaemia syndromes. Medicine. London, United Kingdom: University of London; 1999.
20. Chen Q, Schlichtherle M, Wahlgren M. Molecular aspects of severe malaria. Clin Microbiol Rev. 2000;13:439-450.
21. Clark IA, Cowden WB, Ba FD. The pathophysiology of falciparum malaria. Pharmacol Ther. 2003; 99:221-260.
22. Dondorp AM, Kager PA, Vreeken J, White NJ. Abnormal blood flow and red blood cell deformability in severe malaria. Parasitol Today. 2000; 16:228-232.
23. Menendez C, Fleming AF, Alonso PL Malaria-related anaemia. Parasitol Today. 2000;16:469-476.
24. Maitland K, Newton CR. Acidosis of severe falciparum malaria: heading for a shock? Trends Parasitol. 2005;21:11-16.
25. Cockburn IA, Mackinnon MJ, O'Donnell A, et al. A human complement receptor 1 polymorphism that reduces Plasmouium falciparum resetting confers protection against severe malaria. Proc Natl Acad Sci U S A. 2004;101:272-277.